ALXP
ALECR
Market cap103mUSD
Oct 16, Last price
18,400.00EUR
Name
Eurofins-Cerep SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1989 and headquartered in Vienne, France, Eurofins Cerep SA delivers a broad spectrum of drug discovery support to pharmaceutical and biotechnology enterprises across the globe. The company's specialized offerings include the management of chemical compounds, high-throughput screening capabilities, in vitro safety assessments, optimization of lead compounds (SAR profiling), in vitro ADME evaluations, and in vivo pharmacokinetic (PK) studies. Furthermore, it provides expert services in assay development and design. The organization, originally known as Cerep SA, officially adopted the name Eurofins Cerep SA in June 2014.
Key people
Damien Seroux
Chairman of the Board, Chief Executive Officer · since 2014
Sophie Macault
Member of the Executive Committee, General Counsel and Corporate Secretary
Olivier Goze
Member of the Executive Committee and Director of Preclinical Operations
Pierre Bart
Director · since 2008
Monique Capron
Director · since 2006
Frederic Revah
Director · since 2008
Headquarters & legal address
2 RUE DU PROFESSEUR GARGOUIL
CELLE-LEVESCAULT 86600
FR
CELLE-LEVESCAULT 86600
FR
Previous name
EUROFINS-CEREP
Valuation
Title EUR in thousands, except ratios and share amounts | FY |
|---|---|
| 2025‑12 | |
| Income | |
Revenues | |
Cost of revenue | |
Unusual Expense (Income) | |
NOPBT | |
NOPBT Margin | |
Operating Taxes | |
Tax Rate | |
NOPAT | |
Net income | |
Dividends | |
Dividend yield | |
Proceeds from repurchase of equity | |
BB yield | |
| Debt | |
Debt current | |
Long-term debt | |
Deferred revenue | |
Other long-term liabilities | |
Net debt | |
| Cash flow | |
Cash from operating activities | |
CAPEX | |
Cash from investing activities | |
Cash from financing activities | |
FCF | |
| Balance | |
Cash | |
Long term investments | |
Excess cash | |
Stockholders' equity | |
Invested Capital | |
ROIC | |
ROCE | |
| EV | |
Common stock shares outstanding | |
Price | |
Market cap | |
EV | |
EBITDA | |
EV/EBITDA | |
Interest | |
Interest/NOPBT | |